Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure
Status:
Terminated
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
Beta-blocker medications have been shown to improve heart function and prolong the lives of
patients with chronic heart failure (CHF). Some people with advanced CHF have difficulty
taking beta-blocker medications due to troublesome side effects, such as low blood pressure
and/or low heart rate, severe tiredness, dizziness, or shortness of breath. In other words,
they have difficulty tolerating beta-blocker medications. The purpose of this study is to
determine if enoximone can improve a patient's ability to tolerate a beta-blocker medication.